Misoprostol priming prior to second trimester medical abortion.
Moreno-Ruiz
Nilda L
NL
Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA, USA. Nilda.Moreno@BMC.org
Vesona
Jenny L
JL
Betstadt
Sarah J
SJ
Feng
Kui-Tzu
KT
Borgatta
Lynn
L
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000379:methods*; D000278:Administration, Buccal; D020070:Cervical Ripening / Q000187:drug effects; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D013997:Time Factors; D016896:Treatment Outcome
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; D004077:Digoxin